Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 15, 2008 02:00 ET | Source: Summit Therapeutics plc

Positive results from Phase I clinical trial in acne

Summit Corporation plc ("Summit plc" or "the Company") POSITIVE RESULTS FROM PHASE I CLINICAL TRIAL OF SMT D002 FOR THE TREATMENT OF SEBORRHOEA, A PRIMARY CAUSE OF ACNE SMT D002...
April 09, 2008 04:30 ET | Source: Summit Therapeutics plc

Zebrafish Data Presented at International Conferences

Summit Corporation plc ("Summit" or "the Company") SUMMIT PRESENTS THE BENEFITS ZEBRAFISH BRING TO DRUG DISCOVERY AND DEVELOPMENT AT TWO INTERNATIONAL CONFERENCES Oxford, UK, 9...
April 01, 2008 11:14 ET | Source: Summit Therapeutics plc

Total voting rights

Summit Corporation plc ("Summit plc" or "the Company") Oxford, UK, 2 April 2008 - Summit Corporation plc (AIM: SUMM) notifies the market of the following information in order to conform...
March 25, 2008 07:15 ET | Source: Summit Therapeutics plc

Additional Listing

Summit Corporation plc ("Summit plc" or "the Company") ADDITIONAL LISTING Oxford, UK, 25 March 2008 - Summit Corporation plc (AIM: SUMM), a leading UK biotechnology company,...
February 21, 2008 02:00 ET | Source: Summit Therapeutics plc

Re Contract

Summit Corporation plc ("Summit plc" or "the Company") SUMMIT PLC ANNOUNCES CONTRACT WINS BY DEXTRA CARBOHYDRATE SERVICE BUSINESS £500,000 GMP service contracts signed with potential...
February 05, 2008 11:17 ET | Source: Summit Therapeutics plc

PAYMENT OF NON-EXECUTIVE DIRECTORS' FEES IN SHARES

Oxford, UK, 5 February 2008 - Summit Corporation plc (AIM: SUMM) today announces that two Non-executive Directors of the Company have taken all or part of their fees for the quarter ended 31 January...